07:00 , Jul 1, 2013 |  BC Week In Review  |  Financial News

Complix completes venture financing

Complix N.V. , Diepenbeek, Belgium   Business: Autoimmune, Infectious, Cancer   Date completed: 6/26/13   Type: Venture financing   Raised: €12 million ($15.7 million)   Investors: Edmond de Rothschild Investment Partners; Gimv N.V.; Biotech Fund...
07:00 , Sep 13, 2010 |  BC Week In Review  |  Financial News

Arcarios completes venture financing

Arcarios B.V. , Rotterdam, the Netherlands   Business: Autoimmune, Musculoskeletal   Date completed: 9/8/10   Type: Venture financing   Raised: €4.1 million ($5.3 million)   Investors: BioGeneration Ventures; TiGenix N.V. ; Erasmus MC Biomedical; Gemma...
07:00 , Sep 6, 2010 |  BioCentury  |  Emerging Company Profile

Complix: Scaffolds with a twist

Complix N.V. believes the protein scaffolds created with its Alphabody technology will have greater stability and diversity than therapeutics based on other protein scaffolds. The resulting therapeutics could bind their targets with greater affinity than...
07:00 , Jul 6, 2009 |  BC Week In Review  |  Financial News

Pronota completes venture financing

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Date completed: 6/29/09   Type: Venture financing   Raised: €4.9 million ($6.9 million)   Investors: LSP-Life Sciences Partners; Gimv N.V.; Biotech Fund Flanders; KBC Private...
08:00 , Feb 19, 2007 |  BioCentury  |  Finance

Ebb & Flow

When Invitrogen bought BioReliance for $500 million in cash in early 2004, the rationale was clear: make a bioproduction powerhouse by coupling services with products. The deal combined IVGN's media, sera, reagents, packaging and cell...
00:48 , Aug 23, 2006 |  BC Extra  |  Financial News

Peakadilly raises $10.6 million

Peakadilly (Ghent, Belgium) raised EUR 8.5 million ($10.9 million) in the final close of a series A round. Investors included GIMV; Life Science Partners; KBC Private Equity; and Baekeland Fonds II. The final close brings...